Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

INTRODUCTION: Complex underlying risk functions associated with immuno-oncology treatments have led to exploration of different methods (parametric survival, spline, landmark, and cure-fraction models) to estimate long-term survival outcomes. The objective of this study was to examine differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanitis, Tereza, Proskorovsky, Irina, Ambavane, Apoorva, Hunger, Matthias, Zheng, Ying, Bharmal, Murtuza, Phatak, Hemant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822847/
https://www.ncbi.nlm.nih.gov/pubmed/31350728
http://dx.doi.org/10.1007/s12325-019-01034-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822847/
https://www.ncbi.nlm.nih.gov/pubmed/31350728
http://dx.doi.org/10.1007/s12325-019-01034-0

Ejemplares similares